Detalhe da pesquisa
1.
A pleiotropic variant in DNAJB4 is associated with multiple myeloma risk.
Int J Cancer
; 152(2): 239-248, 2023 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36082445
2.
Polymorphisms within Autophagy-Related Genes as Susceptibility Biomarkers for Multiple Myeloma: A Meta-Analysis of Three Large Cohorts and Functional Characterization.
Int J Mol Sci
; 24(10)2023 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37239846
3.
Expression quantitative trait loci of genes predicting outcome are associated with survival of multiple myeloma patients.
Int J Cancer
; 149(2): 327-336, 2021 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33675538
4.
Common gene variants within 3'-untranslated regions as modulators of multiple myeloma risk and survival.
Int J Cancer
; 148(8): 1887-1894, 2021 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33152124
5.
Safety and Efficacy of Bendamustine Monotherapy in the First-Line Treatment of Patients with Chronic Lymphocytic Leukemia: Polish Lymphoma Research Group Real-Life Analysis.
Chemotherapy
; 64(3): 155-162, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31715597
6.
Inherited variation in the xenobiotic transporter pathway and survival of multiple myeloma patients.
Br J Haematol
; 183(3): 375-384, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30079960
7.
Identification of miRSNPs associated with the risk of multiple myeloma.
Int J Cancer
; 140(3): 526-534, 2017 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27718532
8.
Addition of cladribine to the standard induction treatment improves outcomes in a subset of elderly acute myeloid leukemia patients. Results of a randomized Polish Adult Leukemia Group (PALG) phase II trial.
Am J Hematol
; 92(4): 359-366, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28103640
9.
Characteristics and outcomes of patients with multiple myeloma aged 21-40 years versus 41-60 years: a multi-institutional case-control study.
Br J Haematol
; 175(5): 884-891, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27682187
10.
Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) with probable mesentery involvement with associated hemophagocytic syndrome (HPS) - how to treat it?
J Dermatolog Treat
; 33(5): 2674-2676, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32924664
11.
A polygenic risk score for multiple myeloma risk prediction.
Eur J Hum Genet
; 30(4): 474-479, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34845334
12.
Does a Multiple Myeloma Polygenic Risk Score Predict Overall Survival of Patients with Myeloma?
Cancer Epidemiol Biomarkers Prev
; 31(9): 1863-1866, 2022 09 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35700034
13.
Bendamustine-Based Regimens as Salvage Therapy in Refractory/Relapsed Multiple Myeloma Patients: A Retrospective Real-Life Analysis by the Polish Myeloma Group.
J Clin Med
; 10(23)2021 Nov 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34884206
14.
Cladribine Combined with Low-Dose Cytarabine as Frontline Treatment for Unfit Elderly Acute Myeloid Leukemia Patients: Results from a Prospective Multicenter Study of Polish Adult Leukemia Group (PALG).
Cancers (Basel)
; 13(16)2021 Aug 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34439342
15.
Genetically determined telomere length and multiple myeloma risk and outcome.
Blood Cancer J
; 11(4): 74, 2021 04 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33854038
16.
The Efficacy of Cladribine (2-CdA) in Advanced Systemic Mastocytosis.
Indian J Hematol Blood Transfus
; 36(4): 661-666, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-33093752
17.
Early induction intensification with cladribine, cytarabine, and mitoxantrone (CLAM) in AML patients treated with the DAC induction regimen: a prospective, non-randomized, phase II study of the Polish Adult Leukemia Group (PALG).
Leuk Lymphoma
; 61(3): 588-603, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31661339
18.
Cereblon (CRBN) gene polymorphisms predict clinical response and progression-free survival in relapsed/refractory multiple myeloma patients treated with lenalidomide: a pharmacogenetic study from the IMMEnSE consortium.
Leuk Lymphoma
; 61(3): 699-706, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31746254
19.
Pixantrone, etoposide, bendamustine, rituximab (P[R]EBEN) as an effective salvage regimen for relapsed/refractory aggressive non-Hodgkin lymphoma-Polish Lymphoma Research Group real-life analysis.
Pharmacol Rep
; 71(3): 473-477, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-31003160
20.
Multiple myeloma in patients up to 30 years of age: a multicenter retrospective study of 52 cases.
Leuk Lymphoma
; 60(2): 471-476, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30033832